Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
T-DM1 and Osimertinib Combination Treatment to Target HER2 Bypass Track Resistance in EGFR Mutation Positive NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Olaparib for PAH: a Multicenter Clinical Trial
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2
- Status
- COMPLETED
- Phase
- PHASE4
A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2)
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Compare the Pharmacokinetics of Budesonide and Albuterol Delivered by PT027 Compared With PT007 and PT008 Administered Separately.
- Status
- COMPLETED
- Phase
- PHASE1
AZD6738 for Patients With Progressive MDS or CMML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449
- Status
- COMPLETED
- Phase
- PHASE1
Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in Belgium
- Status
- COMPLETED
- Phase
- N/A
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Safety and Tolerability Study of AZD4831 in Patients With Heart Failure.
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of MEDI7352 in Participants With Painful Diabetic Neuropathy
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2